Published
UROONCO PCa chief editor Dr. Giancarlo Marra talks to Prof. Fred Saad on the ARANOTE study: Darolutamide in combination with androgen-deprivation therapy in patients with metastatic hormone-sensitive prostate cancer (mHSPC).
- Category
- Oncology
Be the first to comment
Up Next
-
04:09
Upcoming Trials for mHSPC and mCRPC and Next-Generation Sequencing
-
08:51
15. Darolutamida: Revisión del estudio Aranote - Dr. Matthew Smith | Uroconect
-
08:03
Treatment Considerations After New Data: ARASENS, ARANOTE, and PEACE-3
-
07:45
AIM Higher Clinical Study for Patients
-
09:41
Unexpected Findings in Study of Gene Mutations for Pediatric Cancer Patients
-
11:16
EXCLUSIVE! 11 Signs of Heart Damage You CAN’T Ignore!
-
13:03
NEJM Interview: Andrew Hantel on a source of discrimination against some patients in cancer resea...
-
11:54
How do we study our minds? | Introduction to Psychology 1 of 30 | Study Hall
-
09:15
Patient Characteristics to Consider for Doublet, Triplet Therapy in mHSPC and mCRPC
-
08:12
మూడో కన్ను తెరిచిన అఘోర..! | Aghora Exclusive Full Interview | Sri Swamy Siddhayogi | SumanTV
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
